UNIVERSAL PHARMA
0447.382.113 · rovalta.com · 21/09/2026
UNIVERSAL PHARMA
Overview
What does UNIVERSAL PHARMA do?
UNIVERSAL PHARMA is a Public limited company incorporated in 1992. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries. It employs on average 134,5 ETP workers (FTE).
7080 Frameries · WallonieSee on map
Joint committees (1)
- 313
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Revenue | 51,5 M € | +5.9% | 48,7 M € | +16.7% | 41,7 M € | +5.0% | 39,7 M € | +6.5% | 37,3 M € | +0.7% | 37,1 M € | +5.0% | 35,3 M € | +3.0% | 34,3 M € | -3.4% | 35,5 M € | +0.6% | 35,3 M € | +10.8% | 31,8 M € | +0.7% | 31,6 M € | +14.2% | 27,7 M € | +6.9% | 25,9 M € | -1.4% | 26,3 M € | +9.6% | 23,9 M € | +7.7% | 22,2 M € | +4.3% | 21,3 M € | +6.6% | 20 M € | +5.4% | 19 M € |
| EBITDA | 3,1 M € | +13.5% | 2,7 M € | +33.4% | 2 M € | -19.5% | 2,5 M € | -14.9% | 3 M € | +77.2% | 1,7 M € | +32.4% | 1,3 M € | -19.9% | 1,6 M € | +8.6% | 1,4 M € | +3.5% | 1,4 M € | +123% | 627 k € | -46.1% | 1,2 M € | +27.7% | 911,9 k € | +133% | 391,4 k € | -38.6% | 637,3 k € | +31.0% | 486,6 k € | +16.1% | 419 k € | +73.2% | 241,9 k € | -64.2% | 676,3 k € | -21.5% | 861,1 k € |
| Operating result | 2,3 M € | +12.4% | 2 M € | +42.9% | 1,4 M € | -30.9% | 2,1 M € | -17.0% | 2,5 M € | +114% | 1,2 M € | +51.7% | 767,1 k € | -27.3% | 1,1 M € | +13.5% | 930,1 k € | +3.5% | 898,8 k € | +634% | 122,5 k € | -81.6% | 664,9 k € | +66.0% | 400,6 k € | +676% | -69,6 k € | -139% | 176,5 k € | +350% | 39,2 k € | +211% | -35,5 k € | +79.8% | -175,5 k € | -160% | 290,9 k € | -40.4% | 488,3 k € |
| Net result | 2 M € | +9.7% | 1,9 M € | +33.0% | 1,4 M € | -27.4% | 1,9 M € | -13.3% | 2,2 M € | +0.3% | 2,2 M € | +128% | 970,3 k € | -18.3% | 1,2 M € | +15.9% | 1 M € | -16.4% | 1,2 M € | +7.6% | 1,1 M € | +33.2% | 854,7 k € | +23.7% | 691 k € | +463% | 122,7 k € | -75.8% | 506,6 k € | +22.0% | 415,4 k € | +34.4% | 309 k € | +13.9% | 271,3 k € | -44.3% | 487,5 k € | -16.5% | 583,9 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 23,1 M € | +8.4% | 21,3 M € | +5.5% | 20,2 M € | +2.0% | 19,8 M € | +10.8% | 17,8 M € | +14.2% | 15,6 M € | +16.5% | 13,4 M € | +7.8% | 12,4 M € | +10.6% | 11,3 M € | +10.0% | 10,2 M € | +13.6% | 9 M € | +14.5% | 7,9 M € | +12.2% | 7 M € | +10.9% | 6,3 M € | +2.0% | 6,2 M € | +8.9% | 5,7 M € | +7.9% | 5,3 M € | +6.2% | 5 M € | +5.8% | 4,7 M € | +11.6% | 4,2 M € |
| Total assets | 31,5 M € | +8.8% | 29 M € | +0.0% | 29 M € | +8.7% | 26,6 M € | +12.5% | 23,7 M € | +3.4% | 22,9 M € | +6.3% | 21,6 M € | +7.3% | 20,1 M € | +4.6% | 19,2 M € | +3.2% | 18,6 M € | +9.5% | 17 M € | +3.0% | 16,5 M € | -1.4% | 16,7 M € | +11.0% | 15,1 M € | -6.6% | 16,1 M € | +9.6% | 14,7 M € | +18.8% | 12,4 M € | +13.6% | 10,9 M € | -2.8% | 11,2 M € | +0.3% | 11,2 M € |
| Cash | 5,2 M € | +28.3% | 4 M € | -12.7% | 4,6 M € | +41.7% | 3,3 M € | +69.2% | 1,9 M € | -25.4% | 2,6 M € | -17.4% | 3,1 M € | +13.1% | 2,8 M € | +62.5% | 1,7 M € | +12.4% | 1,5 M € | +72.9% | 875,5 k € | +47.7% | 592,6 k € | -48.8% | 1,2 M € | +70.9% | 676,8 k € | -36.4% | 1,1 M € | -14.7% | 1,2 M € | +28.5% | 971,5 k € | +1.2% | 960,1 k € | +40.2% | 684,9 k € | +59.9% | 428,3 k € |
| Debts | 8,2 M € | +12.2% | 7,3 M € | -13.0% | 8,4 M € | +23.7% | 6,8 M € | +22.1% | 5,6 M € | -20.8% | 7,1 M € | -10.6% | 7,9 M € | +5.1% | 7,5 M € | -2.8% | 7,7 M € | -7.0% | 8,3 M € | +5.2% | 7,9 M € | -7.5% | 8,5 M € | -11.8% | 9,7 M € | +11.3% | 8,7 M € | -12.0% | 9,9 M € | +9.9% | 9 M € | +28.1% | 7 M € | +19.4% | 5,9 M € | -9.4% | 6,5 M € | -6.0% | 6,9 M € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 134,5 ETP | -0.8% | 135,6 ETP | +2.6% | 132,1 ETP | +9.2% | 121,0 ETP | +4.3% | 116,0 ETP | -4.9% | 122,0 ETP | +3.4% | 118,0 ETP | +8.3% | 109,0 ETP | +1.7% | 107,2 ETP | -0.6% | 107,9 ETP | +2.5% | 105,3 ETP | +4.2% | 101,1 ETP | +9.4% | 92,4 ETP | +10.1% | 83,9 ETP | +89.8% | 44,2 ETP | +8.1% | 40,9 ETP | +4.3% | 39,2 ETP | +7.1% | 36,6 ETP | -1.6% | 37,2 ETP | -19.3% | 46,1 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 17 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
ASSCOT● Active | 0447.778.625 |
ATRIUM MANAGEMENT● Active | 0478.169.913 |
BEPHAR● Active | 0450.260.538 |
EVRAS● Active | 0417.723.174 |
FARMIMMO● Active | 0429.198.175 |
FELIX PHARMA● Active | 0477.939.091 |
| 0443.155.782 | |
Immobilière Général Léman● Active | 0403.358.761 |
IMMOBILIERE PRIMA● Active | 0466.956.812 |
IMMOBILIERE SAINT GEORGES● Active | 0435.700.442 |
Les Pharmacies Réunies● Active | 0403.082.213 |
OBIPHAR● Active | 0878.100.418 |
PHARMACIE ANDROMEDE● Active | 0882.318.631 |
PHARMACIE CLAERHOUT● Active | 0423.162.203 |
Pharmacie de la Chasse Royale● Active | 0867.368.654 |
PHARMACIE DE LA PLACE DE GHLIN● Active | 0842.900.009 |
PHARMACIE FAIDHERBE● Active | 0479.179.208 |
Pharmacie Grenez - Seeuws● Active | 0419.745.130 |
PHARMACIE RONDEAU● Active | 0447.088.737 |
PHARMACIE SCHNEIDER - DEPOUHON● Active | 0439.400.397 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/07/2026 | 03/07/2025 | 28/08/2024 | 26/07/2023 | 18/08/2022 | 17/08/2021 |
| General meeting | 30/06/2026 | 30/06/2025 | 30/06/2024 | 28/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
21 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 30/06/2026 | 07/07/2026 | French | |
| Full model | 31/12/2024 | 30/06/2025 | 03/07/2025 | French | |
| Full model | 31/12/2023 | 30/06/2024 | 28/08/2024 | French | |
| Full model | 31/12/2022 | 28/06/2023 | 26/07/2023 | French | |
| Full model | 31/12/2021 | 30/06/2022 | 18/08/2022 | French | |
| Full modelCorrection | 31/12/2020 | 30/06/2021 | 17/08/2021 | French | |
| Full model | 31/12/2020 | 30/06/2021 | 09/08/2021 | French | |
| Full model | 31/12/2019 | 26/06/2020 | 12/08/2020 | French | |
| Full model | 31/12/2018 | 30/06/2019 | 08/08/2019 | French | |
| Full model | 31/12/2017 | 08/06/2018 | 02/08/2018 | French | |
| Full model | 31/12/2016 | 30/06/2017 | 17/07/2017 | French | |
| Full model | 31/12/2015 | 30/06/2016 | 26/07/2016 | French | |
| Full model | 31/12/2014 | 30/06/2015 | 29/07/2015 | French | |
| Full model | 31/12/2013 | 30/06/2014 | 28/07/2014 | French | |
| Full model | 31/12/2012 | 30/06/2013 | 12/07/2013 | French | |
| Full model | 31/12/2011 | 30/06/2012 | 09/07/2012 | French | |
| Full model | 31/12/2010 | 30/06/2011 | 29/07/2011 | French | |
| Full model | 31/12/2009 | 30/06/2010 | 26/08/2010 | French | |
| Full model | 31/12/2008 | 25/06/2009 | 05/08/2009 | French | |
| Full model | 31/12/2007 | 13/06/2008 | 22/08/2008 | French | |
| Full model | 31/12/2006 | 08/06/2007 | 02/08/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 17 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates04/12/2024DEMISSIONS, NOMINATIONS
- Mandates29/12/2023DEMISSIONS, NOMINATIONS
- Other20/10/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates22/12/2021DEMISSIONS, NOMINATIONS - DIVERS
- Mandates06/11/2020DEMISSIONS, NOMINATIONS
- Mandates03/08/2016DEMISSIONS, NOMINATIONS
- Other27/12/2013STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Restructuring23/07/2012CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20252 M €↑
- 2024Annual accounts 20241,9 M €↑
- 2023Annual accounts 20231,4 M €↓
- 2022Annual accounts 20221,9 M €↓
- 2021Annual accounts 20212,2 M €↑
- 2020Annual accounts 20202,2 M €↑
- 2019Annual accounts 2019970,3 k €↓
- 2018Annual accounts 20181,2 M €↑
- 2017Annual accounts 20171 M €↓
- 2016Annual accounts 20161,2 M €↑
- 2015Annual accounts 20151,1 M €↑
- 2014Annual accounts 2014854,7 k €↑
- 2013Annual accounts 2013691 k €↑
- 2012Annual accounts 2012122,7 k €↓
- 2011Annual accounts 2011506,6 k €↑
- 2010Annual accounts 2010415,4 k €↑
- 2009Annual accounts 2009309 k €↑
- 2008Annual accounts 2008271,3 k €↓
- 2007Annual accounts 2007487,5 k €↓
- 2006Annual accounts 2006583,9 k €
- 12/05/1992IncorporationPublic limited company